ASP Isotopes (NASDAQ:ASPI – Get Free Report) is projected to release its Q1 2025 earnings data before the market opens on Wednesday, May 21st. Analysts expect ASP Isotopes to post earnings of ($0.09) per share and revenue of $1.30 million for the quarter.
ASP Isotopes Stock Performance
Shares of NASDAQ ASPI opened at $7.29 on Monday. The stock has a fifty day moving average price of $5.21 and a two-hundred day moving average price of $5.43. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. The firm has a market cap of $547.20 million, a P/E ratio of -11.95 and a beta of 3.40. ASP Isotopes has a 1 year low of $1.86 and a 1 year high of $9.33.
Insider Buying and Selling at ASP Isotopes
In other ASP Isotopes news, COO Robert Ainscow sold 66,666 shares of the stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total transaction of $383,329.50. Following the completion of the transaction, the chief operating officer now directly owns 1,553,326 shares of the company’s stock, valued at approximately $8,931,624.50. This trade represents a 4.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Paul Elliot Mann sold 316,666 shares of the stock in a transaction on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $1,779,662.92. Following the transaction, the chief executive officer now directly owns 7,315,454 shares of the company’s stock, valued at approximately $41,112,851.48. The trade was a 4.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 766,667 shares of company stock valued at $4,358,502. 21.40% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On ASP Isotopes
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Featured Stories
- Five stocks we like better than ASP Isotopes
- What is the Nasdaq? Complete Overview with History
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Savvy Investors Are Raising a Glass for Heineken Stock
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.